Catalent Argentina S.A.I.C.August 4, 2023

FDA 483 - Catalent Argentina S.A.I.C. - August 04, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Catalent Argentina S.A.I.C.

Record Details

An FDA inspection of Catalent Argentina S.A.I.C. in Buenos Aires, Argentina, revealed significant deficiencies in laboratory controls and facility design. The firm's analytical procedures for drug products were found to be inadequate, lacking proper method transfer verification and stability-indicating studies. Additionally, the facility's areas for preparing different products were not sufficiently separated, creating a risk of contamination and mix-ups.

Company: Catalent Argentina S.A.I.C.
Inspection Date: August 4, 2023
Product Type: Drugs
Office: Office of Biological Products Operations - Division I
Person: Saied A. Asbagh (Investigator)

Open in Dashboard

ID · cbabcbc7-9031-467b-b457-3a7b2e4658bc